Join leading researchers, clinicians, policy experts and industry partners for three days that follow early detection from the first biological changes in a cell to the benefit for patients and society.

Day 1: Bench
Fundamental mechanisms, cancer genomics and risk. We open with a visionary keynote on when early detection actually works. We then explore how precancer arises in normal tissue, how to tell progressive from indolent disease, and which risk factors and hereditary predispositions matter for early detection. The day ends with PhD presentations, poster pitches and a poster session with drinks.

Day 2: Bridge
Biomarkers, technology and AI. Sessions on liquid biopsies and volatile organic compounds, tissue-based biomarkers, advanced medical imaging and medtech, AI and digital pathology, and multi-cancer early detection (MCED). The day includes a second round of PhD presentations, poster pitches and posters, and closes with the conference dinner.

Day 3: Benefit
Precision screening, healthcare equity and implementation science. We look at what real-world evidence and modelling tell us about early detection in practice, new screening strategies and the latest trial results, and which findings have really progressed population surveillance. An interactive panel discussion addresses health inequalities in the Dutch context, and the conference closes with a plenary debate on screening.

Throughout the conference there is room for networking, early-career researchers and the posters.

Speakers will be announced soon. Stay tuned!

Registration for the NKI Early Cancer Detection Conference 2027 is now open! Join us in Amsterdam from May 26-28, 2027.

Action buttons: [register]

What’s included in your ticket?

All conference passes include full access to the three-day program and the following benefits:

• Full admission to all plenary sessions, keynote lectures, and parallel breakout tracks
• Daily networking lunches, coffee breaks, and refreshments
• Access to the exhibition hall and interactive poster sessions
•  Entry to the official Conference Dinner
• Official digital certificate of attendance and digital Abstract Book
• Note: All registration fees include local VAT.

Important: CME / GAIA Accreditation (points requested for medical specialists)

LMIC: * We are committed to making the conference accessible to researchers and healthcare professionals globally.

·      Eligibility: Applicable exclusively to delegates currently residing and working in low-, lower-middle-, or upper-middle-income economies, as classified by the World Bank Gross National Income (GNI) per capita criteria at the time of application.

·     How to apply: If you qualify for the LMIC rate, please reach out to us at earlydetection2027@nki.nl  to receive a link to the registration form. Proof of institutional affiliation may be requested during registration.

Patients/people affected by cancer: ** We are committed to including patient perspectives in early detection research. To foster meaningful discussions between researchers, clinicians and the community, a number of complimentary passes are available for patient representatives and individuals affected by cancer.

·         Eligibility: available to patient advocates, patient organization representatives and individuals affected by cancer.

·         How to apply: if you are interested in attending, please reach out to us at earlydetectionconference@nki.nl

·         Applications are reviewed on a rolling basis, so we encourage early submission as places are limited. 

Key registration deadlines:

·         Early bird deadline: February 28, 2027 (23:59 CET)

        Online registration closes: May 25, 2027